NIH Guidelines for Asthma


Asthma is a chronic and potentially life-threatening condition that affects millions of people around the world. This disorder involves inflammation and obstruction of the airways, often producing breathlessness or wheezing. Common symptoms also include coughing, chest tightness, and rapid breathing. Asthma can be triggered by exercise, allergies, exposure to certain irritants in the air, and emotional stress. Fortunately, a variety of treatments has been developed to help control and manage asthma. The most current guidelines for the diagnosis and treatment of asthma are those established by the National Institutes of Health (NIH). This includes the use of medications to reduce inflammation and improve lung function, as well as a number of lifestyle modifications such as avoiding exposure to triggers, exercising regularly, and managing stress levels. Following these guidelines can significantly reduce the severity of asthma symptoms and improve quality of life for those who suffer from this condition.


Asthma is a chronic respiratory disease that can be debilitating if not properly managed. The National Institutes of Health (NIH) has developed guidelines to help patients and health care providers treat and manage asthma. The goals of these guidelines are to: 1) reduce the frequency of asthma attacks, 2) improve quality of life, and 3) reduce or eliminate the need for inhalers or other medications. The guidelines provide the following recommendations for medicines when treating asthma:

  1. Inhaled corticosteroids: These are used to reduce inflammation in the airways and to help prevent asthma attacks.
  2. Short-acting beta2-agonists: These act quickly to relax the muscles of the airways during an attack and can also be used for prevention.
  3. Long-acting beta2-agonists: These are used to provide long-term control of asthma symptoms and can also be used in combination with other medications.
  4. Leukotriene modifiers: These are used to reduce the production of substances in the body that can trigger an asthma attack.
  5. Theophylline: This is a bronchodilator that helps relax the muscles of the airways and can also be used for prevention.
  6. Immunomodulators: These are used to reduce the severity of asthma attacks and also used to prevent future attacks.

While there may be other medications prescribed by an individual’s health care provider, these medicines are the core treatments for asthma per the NIH guidelines. Patients should discuss their medication options with a health care provider to create the best plan for their specific needs.


The National Institutes of Health (NIH) has created guidelines for asthma management, and medical professionals should follow them to ensure best outcomes for their patients. When prescribing medication, there are certain criteria that must be met to ensure safe and effective treatment.

  1. The medication should be used to reduce the frequency of exacerbations and improve pulmonary function.
  2. The dose should be tailored to each patient to ensure the lowest possible dose that is required to achieve adequate control.
  3. The medication should be suitable for the patient’s age and other health conditions.
  4. The medication should not be contraindicated with other medications the patient is taking.
  5. The patient must be monitored to assure that the treatment is effective.
  6. The patient must be monitored for any potential side effects of the medications.

It is important for physicians to adhere to these guidelines, to ensure safe and effective asthma treatment for all patients.


Research into asthma management has been of paramount importance in the development of National Institutes of Health (NIH) guidelines. NIH has undertaken extensive clinical and laboratory studies to understand the intricate relationship between asthma symptoms, environmental exposures and genetics. These studies show that asthma is different for each person and requires individualized treatments. The NIH’s asthma guidelines also emphasize using a step-wise approach to assess and manage asthma based on the needs and characteristics of the individual. This includes focusing on the use of medications to suppress airway inflammation and improve lung function, while also focusing on reducing exposure to environmental triggers. With this individualized approach, NIH aims to empower patients to gain control over their asthma and live healthy, active lives.

Clinical Practice

Asthma is a chronic lung condition that affects millions of people around the world. The National Institutes of Health (NIH) provides clinical practice guidelines for the management of asthma in adults and children. An important part of these guidelines is the appropriate use of medications for treating asthma. Long-term control medications, such as inhaled corticosteroids, are used to reduce and prevent asthma symptoms. Quick-relief medications, such as short-acting beta-agonists, are used to treat acute asthma symptoms. Guidelines also recommend combination medications that contain both a long-term controller and a quick-relief medication. These medications are used to maintain control of the patient’s asthma, reduce the need for quick-relief medication, and improve their quality of life. The guidelines also provide recommendations for the monitoring and reviewing of medications, as well as for lifestyle and environmental interventions. Ultimately, these clinical practice guidelines are an important resource for clinicians and patients as they work together to control asthma and improve outcomes.


When it comes to diagnosing asthma, the National Institutes of Health (NIH) guidelines recommend the following:

  1. Physicians should take a medical history, including past history of allergic respiratory disease, cigarette smoking, and family history of asthma or allergies.
  2. Physicians should also obtain objective evidence of airway obstruction and inflammation, including pulmonary function tests.
  3. Physicians should use evidence-based medicine to identify asthma triggers and to assess the effectiveness of treatments.
  4. Physicians should also assess the patient’s overall health and evaluate the need for any medications.

These guidelines provide helpful information for physicians when diagnosing asthma, and this helps to ensure that the best treatments are being used for patients.


When treating asthma, medications are necessary to reduce inflammation in the airways and relax the muscles around the airways to make it easier to breathe. These medications include corticosteroids (or anti-inflammatory medications), bronchodilators that open the airways, and leukotriene modifiers. Depending on the severity of the asthma, your doctor may prescribe one or a combination of these drugs. Your doctor may also advise on lifestyle changes such as staying away from triggers or pets that worsen your asthma symptoms. Even if medications are effective in controlling your asthma, you may still be at risk of flare-ups, so you may need to make sure that you are taking preventive measures. That may include regularly taking your medications, attending follow-up visits with your healthcare provider, and monitoring your asthma symptoms. It is important to follow your doctor’s instructions for treatment so that your asthma can be managed and controlled.

Follow-Up Care

For those suffering from asthma, follow-up care is an essential part of their treatment. The National Institutes of Health (NIH) recommends that individuals with asthma visit their healthcare provider for regular checkups and to monitor the severity of their condition. To ensure the best possible outcomes, patients should take note of the following steps: staying current on their medication routine, understanding and adhering to all asthma action plans, being aware of any triggers that can worsen their condition, and attending immunizations and other preventive health appointments. Patients should also keep track of their peak flow rate, which is an indicator of how well their lungs are functioning. Finally, individuals with asthma should always have quick access to their rescue medications in case of a flare-up. Following these guidelines can ensure that individuals with asthma stay healthy, prevent complications, and avoid any further health risks.


When it comes to treating asthma, the National Institutes of Health (NIH) guidelines emphasize outcomes over medicines. It is important to ensure that the treatment you are receiving is effectively managing your asthma symptoms and preventing asthma attacks. The NIH recommends that you work with your provider to develop an asthma action plan that outlines the steps you should take when your asthma is well-controlled and what to do when your asthma is not well-controlled. Your plan should include when to take your medicines, when to call your provider, and when to seek emergency medical care. This plan should be tailored to your individual needs and lifestyle. With proper management, you can achieve the best outcomes for your asthma.


When it comes to managing asthma, it is important to keep track of how well the disease is being managed. Monitoring the patient’s condition is essential in order to ensure that the treatment plan is working and that the patient is responding well to it. The National Institutes of Health (NIH) provide guidelines for monitoring the progress of the patient. This includes tracking the frequency and severity of asthma attacks, the patient’s peak flow readings, and the effectiveness of the medications they are taking. It is also important to keep an eye on the patient’s lung function to make sure that it is not decreasing over time. By monitoring the patient’s asthma, doctors can adjust the treatment plan as needed to ensure that the patient is getting the best possible care and that the condition is kept under control.

No Comments

    Leave a Reply